Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
389
-
Total 13F shares, excl. options
-
85.7M
-
Shares change
-
+1.25M
-
Total reported value, excl. options
-
$11.1B
-
Value change
-
+$166M
-
Put/Call ratio
-
0.9
-
Number of buys
-
243
-
Number of sells
-
-107
-
Price
-
$128.88
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q4 2020
433 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q4 2020.
Guardant Health, Inc. - Common Stock (GH) has 389 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 85.7M shares
of 124M outstanding shares and own 69.23% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (7.62M shares), SB INVESTMENT ADVISERS (UK) LTD (6.34M shares), BlackRock Inc. (5.32M shares), MORGAN STANLEY (4.94M shares), VIKING GLOBAL INVESTORS LP (3.53M shares), Clearbridge Investments, LLC (3.18M shares), JENNISON ASSOCIATES LLC (3.01M shares), FMR LLC (2.77M shares), FRED ALGER MANAGEMENT, LLC (2.07M shares), and Nuveen Asset Management, LLC (2.07M shares).
This table shows the top 389 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.